Hirohito Sugawara
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Association of Serum Calcium Levels With Coronary Artery Calcification in Patients at the Initiation of Hemodialysis.
Journal: Hemodialysis international. International Symposium on Home Hemodialysis
Published: December 05, 2025
Renin-angiotensin system inhibitor use and cardio-renal outcomes in non-proteinuric chronic kidney disease: a post-hoc analysis of the Frontier of Renal Outcome Modification-Japan study.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: July 11, 2025
Hemodialysis-Related Portal-Systemic Encephalopathy Possibly Associated with Right Femoral Vein Thrombosis.
Journal: Internal medicine (Tokyo, Japan)
Published: December 18, 2024
IgG4-Related Pericarditis Diagnosed by Accumulated Pericardial Effusion.
Journal: Case reports in cardiology
Published: January 09, 2023
Seasonal variation of serum 25-hydroxyvitamin D level in hemodialysis patients in the northernmost island of Japan.
Journal: Clinical and experimental nephrology
Published: February 18, 2021
Cardiac Light Chain Deposition Disease Mimicking Immunoglobulin Light Chain Amyloidosis: Two Branches of the Same Tree.
Journal: Circulation. Cardiovascular imaging
Published: September 03, 2020
Activation of the angiotensin II receptor promotes autophagy in renal proximal tubular cells and affords protection from ischemia/reperfusion injury.
Journal: Journal of pharmacological sciences
Published: August 12, 2020
Involvement of necroptosis in contrast-induced nephropathy in a rat CKD model.
Journal: Clinical and experimental nephrology
Published: August 06, 2020
Distinct intra-mitochondrial localizations of pro-survival kinases and regulation of their functions by DUSP5 and PHLPP-1.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: February 04, 2020
mTORC1 inhibition attenuates necroptosis through RIP1 inhibition-mediated TFEB activation.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: April 14, 2019
Canagliflozin, a sodium-glucose cotransporter 2 inhibitor, normalizes renal susceptibility to type 1 cardiorenal syndrome through reduction of renal oxidative stress in diabetic rats.
Journal: Journal of diabetes investigation
Published: October 24, 2018
Last Updated: 09/26/2026